Fact Sheet: President Donald J. Trump Realigns U.S. Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Fact sheetPublished 05/29Open the original
Summary
President Trump recognizes an HHS scientific assessment of childhood vaccines as a guiding resource and directs the CDC and its Advisory Committee on Immunization Practices to review it and update the childhood and adolescent vaccine schedule.
By industry
- Healthcare & Drug Pricing1 trading day−1.0%p15 stocks5 trading days+0.5%p15 stocks20 trading days+8.9%p15 stocks
“take any appropriate steps to update the U.S. childhood and adolescent vaccine schedule”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/05/28 | 0.0% | 0.0% |
| 26/05/29 | −0.9% | +0.1% |
| 26/06/01 | −2.4% | +0.2% |
| 26/06/02 | −3.0% | +0.6% |
| 26/06/03 | −2.5% | −0.6% |
| 26/06/04 | +0.5% | +0.1% |
| 26/06/05 | +1.9% | −2.6% |
| 26/06/08 | +1.4% | −2.2% |
| 26/06/09 | +2.5% | −2.5% |
| 26/06/10 | +1.9% | −4.1% |
| 26/06/11 | +3.1% | −2.1% |
| 26/06/12 | +3.4% | −1.7% |
| 26/06/15 | +2.4% | −0.2% |
| 26/06/16 | +2.4% | −0.6% |
| 26/06/17 | +1.3% | −1.6% |
| 26/06/18 | −0.5% | −1.0% |
| 26/06/22 | +0.7% | −1.5% |
| 26/06/23 | +2.2% | −2.8% |
| 26/06/24 | +2.2% | −2.4% |
| 26/06/25 | +3.4% | −2.8% |
| 26/06/26 | +5.7% | −3.2% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Dermot Mark Durcan
BuyCencora
BuyCencora
COR
$1.1M
4,000 sh
$1.1M
Filed 06/22
Traded 06/18
- Dermot Mark Durcan
BuyCencora
BuyCencora
COR
$1.1M
4,000 sh
$1.1M
Filed 05/28
Traded 05/28
- Lauren M. Tyler
BuyCencora
BuyCencora
COR
$148.6K
550 sh
$148.6K
Filed 06/24
Traded 06/22
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$13.6M
13,620 sh
$13.6M
Filed 05/07
Traded 05/06
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$187.3M
1,983,387 sh
$187.3M
Filed 05/21
Traded 05/19
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$74.6M
797,628 sh
$74.6M
Filed 05/21
Traded 05/20
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$34.6M
370,462 sh
$34.6M
Filed 05/21
Traded 05/21
- John Boozman
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 07/13
Traded 06/04
- Kathryn E. Wengel
SellJohnson & Johnson
SellJohnson & Johnson
JNJ
$2.4M
10,000 sh
$2.4M
Filed 06/12
Traded 06/11
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$2.2M
2,208 sh
$2.2M
Filed 05/07
Traded 05/06
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$14.5M
152,691 sh
$14.5M
Filed 05/21
Traded 05/20
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$1.4M
10,900 sh
$1.4M
Filed 06/02
Traded 06/01
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$11.9M
41,099 sh
$11.9M
Filed 05/14
Traded 05/12
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$11.4M
38,487 sh
$11.4M
Filed 05/14
Traded 05/12
- Tommy Tuberville
Full salePfizer
Full salePfizer
PFE
$15K–$50K
Joint
$15K–$50K
Reported 07/16
Traded 06/08
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$10.3M
34,641 sh
$10.3M
Filed 05/14
Traded 05/12
- Brian S. Tyler
Sell10b5-1 planMcKesson
Sell10b5-1 planMcKesson
MCK
$6.6M
8,463 sh
$6.6M
Filed 06/18
Traded 06/17
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$6.4M
66,881 sh
$6.4M
Filed 05/21
Traded 05/20
- Tilak Mandadi
SellCVS Health
SellCVS Health
CVS
$6.2M
69,551 sh
$6.2M
Filed 05/11
Traded 05/08
- David Cordani
Sell10b5-1 planCigna Group
Sell10b5-1 planCigna Group
CI
$4.6M
15,319 sh
$4.6M
Filed 05/14
Traded 05/12